Hello and Welcome to Patientsville.com, Your Source for all CONCOR information. We are dedicated to provide You with CONCOR safety information. Learn about CONCOR serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
CONCOR Safety Reports
Total CONCOR reports: 10.CONCOR FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 4.
Take CONCOR Side Effects Survey or Share Your CONCOR Story. Read More Here.
Physician from SOUTH AFRICA reported CONCOR problem on Apr 11, 2007. Male patient was diagnosed with hypertension and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, haemorrhagic stroke. CONCOR dosage: 10 MG. During the same period patient was treated with COZAAR, STILNOX. Patient was hospitalized. Patient recovered.
CONCOR problem was reported by a Physician from SOUTH AFRICA on Apr 24, 2007. Male patient was diagnosed with hypertension and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: coma, haemorrhagic stroke, hyperglycaemia, respiratory arrest. CONCOR dosage: 10 MG. During the same period patient was treated with COZAAR, STILNOX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CROATIA (local name: Hrvatska) reported CONCOR problem on June 06, 2007. Female patient, 74 years of age, was diagnosed with cardiac failure and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, injury asphyxiation. CONCOR dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OLIVIN, CORDIPIN, TRAMADOL, VOLTAREN. Patient recovered.
CONCOR problem was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on June 06, 2007. Male patient, 80 years of age, was diagnosed with prostatitis and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, dizziness, gait disturbance, hypotension, syncope. CONCOR dosage: unknown. During the same period patient was treated with NOLICIN. Patient recovered.
Consumer or non-health professional from SWITZERLAND reported CONCOR problem on June 08, 2007. Female patient, 78 years of age, was diagnosed with essential hypertension and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: arrhythmia, asthenia, dilatation atrial, hypervolaemia, hypochloraemia, hypokalaemia, hyponatraemia, hypovolaemia. CONCOR dosage: 12, 5000 MG (12, 5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TORASEM MEPHA, PRETERAX, ESCITALOPRAM, METAMUCIL. Patient was hospitalized. Patient recovered.
CONCOR problem was reported by a Health Professional from GERMANY on June 29, 2006. Female patient, 67 years of age, was diagnosed with hyperkinetic heart syndrome and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: nightmare, psychotic disorder. CONCOR dosage: unknown. Patient recovered.
Consumer or non-health professional from GERMANY reported CONCOR problem on July 13, 2006. Female patient, 77 years of age, was diagnosed with hypertension, abdominal pain upper and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cardiovascular disorder, insomnia, intensive care, nausea, treatment noncompliance, vomiting, weight decreased. CONCOR dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, AMLODIPINE, NEDOLON P, TRAMADOL, ANALGESICS. Patient recovered.
CONCOR problem was reported by a Consumer or non-health professional from SWITZERLAND on July 20, 2006. Female patient, 93 years of age, was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, creatinine renal clearance decreased, dehydration, diarrhoea. CONCOR dosage: unknown. During the same period patient was treated with OXAZEPAM, ZOLPIDEM TARTRATE, TOREM, DANCOR, COVERSUM, FOLVITE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from SLOVAKIA (Slovak Republic) reported CONCOR problem on Oct 02, 2006. Male patient, 90 years of age, was diagnosed with cardiac failure chronic and was treated with CONCOR. CONCOR dosage: 5,00 MG (5 MG, 1 IN 1 D) ORAL. During the same period patient was treated with ACCUPRIL, HYDROCHLOROTHIAZID, FURON, CORVATON. Patient died.
CONCOR problem was reported by a Physician from LEBANON on Aug 03, 2007. Male patient, 71 years of age, weighting 198.4 lb, was diagnosed with angina unstable and was treated with CONCOR. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, gastrointestinal haemorrhage. CONCOR dosage: unknown. During the same period patient was treated with VASCOR, CORVASAL, ASPIRIN, PLAVIX. Patient died on 07/31/2007.